908 Devices Announces Preliminary Income for the Fourth Quarter and Whole 12 months 2021
BOSTON–(Enterprise WIRE)–908 Equipment Inc. (Nasdaq: MASS), a pioneer of reason-developed handheld and desktop mass spec devices for chemical and biomolecular assessment, nowadays announced preliminary, unaudited income for the fourth quarter and total year ended December 31, 2021.
Preliminary unaudited income for the fourth quarter of 2021 is expected to be at minimum $15.1 million, in comparison to $5.7 million in the fourth quarter of 2020, reflecting development of at least 165%.
Preliminary unaudited profits for the 12 months finished December 31, 2021 is envisioned to be at least $41.5 million, as opposed to $26.9 million in total year 2020, reflecting expansion of at minimum 54%.
“We ended the yr with one more potent quarter as we ongoing to execute on our professional method and deliver value to our prospects by means of our mass spec units, which includes meaningful sequential development of our desktop products,” reported Kevin J. Knopp, CEO and Co-founder. “As we search in advance to 2022, we will target on placing several units in our crucial accounts, developing and advancing our goods and applications, broadening our bioanalytics system, and laying the foundation for proteomics and metabolomics possibilities.”
The Company’s preliminary unaudited fourth quarter and entire year 2021 economic effects are estimates only and are matter to revision until the completion of the Company’s 2021 audit. Finish fourth quarter and whole year 2021 monetary effects are envisioned to be introduced in early March.
About 908 Equipment
908 Units Inc. (NASDAQ: MASS) is democratizing laboratory mass spectrometry with its basic handheld and desktop equipment, addressing vital-to-existence programs. The Company’s units are used at the stage-of-have to have to interrogate unidentified and invisible supplies and offer speedy, actionable responses to straight tackle some of the most critical complications in existence sciences investigate, bioprocessing, pharma / biopharma, forensics, and adjacent markets. The Firm is headquartered in the heart of Boston, in which it types and manufactures revolutionary products that convey jointly the electricity of mass spectrometry, microfluidic separations, program automation, and equipment finding out.
Ahead Searching Statements
This push launch features “forward hunting statements” in just the which means of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical details are ahead-wanting statements, together with, with no limitation, statements about fourth quarter and comprehensive year 2021 profits results. Text these as “may,” “will,” “expect,” “plan,” “anticipate,” “estimate,” “intend” and very similar expressions (as very well as other text or expressions referencing upcoming functions, situations or situations) are meant to establish forward-hunting statements. These forward-seeking statements are based mostly on management’s existing expectations and require recognised and unidentified risks, uncertainties and assumptions which might lead to true final results to vary materially from any benefits expressed or implied by any ahead-searching assertion, like the dangers outlined underneath “Risk Factors” and in other places in the Company’s filings with the Securities and Exchange Commission which are accessible on the SEC’s site at www.sec.gov. Extra data will be produced offered in the Company’s yearly and quarterly experiences and other filings that it helps make from time to time with the SEC. Though the Organization believes that the anticipations reflected in its forward-hunting statements are affordable, it cannot ensure foreseeable future benefits. The Corporation has no obligation, and does not undertake any obligation, to update or revise any ahead-on the lookout statement built in this press release to mirror changes considering that the day of this press launch, except as might be essential by law.
